Trial Profile
An Open Label, Two-way Crossover Study to Evaluate the PK Effects of Two Different Wafer Administration Protocols in Healthy Volunteers Under Fasted Conditions.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Aug 2016
Price :
$35
*
At a glance
- Drugs Ketamine (Primary)
- Indications Acute pain; Dental pain
- Focus Pharmacokinetics
- Sponsors iX Biopharma
- 17 Aug 2016 Status changed from recruiting to completed.
- 08 Aug 2016 New trial record